The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework
This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
The primary end point of the phase III trial "Imatinib Mesylate (Gleevec) in Treating Patients with Primary GIST that has been Completely Removed by Surgery" was recurrence free survival with the secondary endpoints of overall survival, efficacy, and safety. The study was closed early with the announcement...
This article describes a new way of performing liposuction, or cosmetic removal of "extra" fat cells, using a laser device instead of the traditional suction device.
GBMs most common primary brain tumor adultsLack of efficacy with treatment options makes new treatments attractive Azixa will improve on present treatments
There are two major indications for SN mappingThe indications are melanoma and breast cancerThere is a need to improve the vehicle used to carry out SN mapping
Breast cancer gets a disproportionate funding in drug development.Other diseases get less drug money funding than breast cancer.Some get even more funding than breast cancer
Nexavar has demonstrated response in HCC.HCC is a disease with few treatment options in advanced stage.Most HCC patients become advanced stage patients.While in US HCC relatively uncommmon cancer, one of the most common around the world.
Nexavar continues to expand its place in the oncology arena.Nexavar is approved for renal cell ca and I suspect hepatocellular approval is not far behind.
Targeted cancer therapy is a revolution in treatment. Targeted therapy will take over from non targeted chemo.
Some drugs are more targeted than others.